Literature DB >> 30062796

Minimally Invasive Implantation of Continuous Flow Left Ventricular Assist Devices: The Evolution of Surgical Techniques in a Single-Center Experience.

Massimiliano Carrozzini1, Jonida Bejko1, Alvise Guariento1, Maurizio Rubino1, Roberto Bianco1, Vincenzo Tarzia1, Dario Gregori2, Tomaso Bottio1, Gino Gerosa1.   

Abstract

In this work we aimed to evaluate the evolution of our surgical experience with the implantation of a continuous flow left ventricular assist device (LVAD), from the original full sternotomy approach to less invasive surgical strategies including mini-sternotomy and/or mini-thoracotomies. We reviewed all consecutive patients implanted with a continuous flow LVAD at our Institute. To exclude the possible bias related to the device used, out of 91 collected LVADs implants, we selected only those patients (n = 42) who received, between 2012 and 2015, the HeartWare HVAD. The analysis focused on the surgical approach used for the LVAD implant. Most of the patients (95%) were affected by dilated or ischemic cardiomyopathy, with an INTERMACS class I-II in the majority of cases (77%). The LVAD implant was performed through a full sternotomy in 10 patients (24%); the remaining 32 cases (76%) were managed with minimally invasive procedures. These were left mini-thoracotomy with upper mini-sternotomy (20 patients, 62%), right and left mini-thoracotomy (7 patients, 22%), and a recently developed left mini-thoracotomy with outflow graft anastomosis to the left axillary artery (5 patients, 16%). The most common adverse event on device was right heart failure (26%). Eighteen patients (43%) were transplanted. Overall estimated 24 months survival (on device or after transplant) was 68 ± 7%. The causal analysis, adjusted by propensity score weighting baseline data and sample size, showed that left mini-thoracotomy with outflow anastomosis to the left axillary artery resulted in a significantly reduced rate of post implant right heart failure (P < 0.01), and mechanical ventilation time (P = 0.049). To conclude, in our series, by applying mini-invasive implant techniques in the majority of cases, mid-term survival of continuous flow LVADs in severely compromised patients was satisfactory. In the adjusted analysis, the left anterior mini-thoracotomy with outflow anastomosis to the left axillary artery showed the most favorable results.
© 2018 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

Entities:  

Keywords:  HVAD; HeartWare; Implant; Left ventricular assist device; Minimally invasive; Surgical technique

Mesh:

Year:  2018        PMID: 30062796     DOI: 10.1111/aor.13339

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  10 in total

1.  How to implant the Jarvik 2000 post-auricular driveline: evolution to a novel technique.

Authors:  Massimiliano Carrozzini; Jonida Bejko; Dario Gregori; Gino Gerosa; Tomaso Bottio
Journal:  J Artif Organs       Date:  2019-04-22       Impact factor: 1.731

Review 2.  Oversampling and replacement strategies in propensity score matching: a critical review focused on small sample size in clinical settings.

Authors:  Daniele Bottigliengo; Ileana Baldi; Corrado Lanera; Giulia Lorenzoni; Jonida Bejko; Tomaso Bottio; Vincenzo Tarzia; Massimiliano Carrozzini; Gino Gerosa; Paola Berchialla; Dario Gregori
Journal:  BMC Med Res Methodol       Date:  2021-11-22       Impact factor: 4.615

3.  Impact of Continuous Flow Left Ventricular Assist Device on Heart Transplant Candidates: A Multi-State Survival Analysis.

Authors:  Massimiliano Carrozzini; Tomaso Bottio; Raphael Caraffa; Jonida Bejko; Olimpia Bifulco; Alvise Guariento; Carlo Mario Lombardi; Marco Metra; Danila Azzolina; Dario Gregori; Marny Fedrigo; Chiara Castellani; Vincenzo Tarzia; Giuseppe Toscano; Antonio Gambino; Vjola Jorgji; Enrico Ferrari; Annalisa Angelini; Gino Gerosa
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964

4.  Marginal versus Standard Donors in Heart Transplantation: Proper Selection Means Heart Transplant Benefit.

Authors:  Olimpia Bifulco; Tomaso Bottio; Raphael Caraffa; Massimiliano Carrozzini; Alvise Guariento; Jonida Bejko; Marny Fedrigo; Chiara Castellani; Giuseppe Toscano; Giulia Lorenzoni; Vincenzo Tarzia; Dario Gregori; Massimo Cardillo; Francesca Puoti; Giuseppe Feltrin; Annalisa Angelini; Gino Gerosa
Journal:  J Clin Med       Date:  2022-05-09       Impact factor: 4.964

5.  Temporary ventricular assist device implantation by sternotomy-avoiding technique for bridge-to-decision therapy: a comparison with conventional implantation.

Authors:  Masatoshi Akiyama; Konosuke Sasaki; Satoshi Kawatsu; Yusuke Suzuki; Tomoyuki Suzuki; Ichiro Yoshioka; Goro Takahashi; Kiichiro Kumagai; Osamu Adachi; Yoshikatsu Saiki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-08-01

Review 6.  Minimally invasive versus conventional continuous-flow left ventricular assist device implantation for heart failure: a meta-analysis.

Authors:  Bufan Zhang; Shaohua Guo; Zean Fu; Zhigang Liu
Journal:  Heart Fail Rev       Date:  2021-04-03       Impact factor: 4.654

7.  COVID-19 infection in left ventricular assist device patients.

Authors:  Antonio Piperata; Tomaso Bottio; Gino Gerosa
Journal:  J Card Surg       Date:  2020-08-21       Impact factor: 1.620

8.  Outcomes of patients with continuous flow left ventricular assist device undergoing emergency endovascular treatment for atraumatic bleeding.

Authors:  Valentina Bernardinello; Giulio Barbiero; Michele Battistel; Caterina Dengo; Roberto Stramare; Giulio Folino; Jonida Bejko; Massimiliano Carrozzini; Vincenzo Tarzia; Gino Gerosa; Tomaso Bottio
Journal:  CVIR Endovasc       Date:  2019-12-09

Review 9.  Minimally invasive ventricular assist device implantation.

Authors:  Ameen Al-Naamani; Florian Fahr; Asim Khan; Christian Bireta; Michael Nozdrzykowski; Stefan Feder; Nikhil Deshmukh; Manal Jubeh; Sandra Eifert; Khalil Jawad; Uwe Schulz; Michael A Borger; Diyar Saeed
Journal:  J Thorac Dis       Date:  2021-03       Impact factor: 2.895

10.  A Device Strategy-Matched Comparison Analysis among Different Intermacs Profiles: A Single Center Experience.

Authors:  Raphael Caraffa; Jonida Bejko; Massimiliano Carrozzini; Olimpia Bifulco; Vincenzo Tarzia; Giulia Lorenzoni; Daniele Bottigliengo; Dario Gregori; Chiara Castellani; Tomaso Bottio; Annalisa Angelini; Gino Gerosa
Journal:  J Clin Med       Date:  2022-08-20       Impact factor: 4.964

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.